Nautilus Biotechnology, Inc. (NAUT)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
2. 06
-0.1
-4.6296%
$
286.32M Market Cap
- P/E Ratio
- Div Yield
6.41M Volume
-0.74 Eps
$ 2.16
Previous Close 
Want to track NAUT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nautilus Biotechnology, Inc. (NAUT) Statistics
Valuation metrics
Market Cap 286.32M
Enterprise value 300.97M
Trailing P/E (ttm) -5
Forward P/E -
PEG ratio -0.34
Price/Sales (ttm) 1,506.97
Price/Book (mrq) 2.18
Enterprise Value/Revenue 1,584.08
Enterprise Value/EBITDA -5.6
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 14.55M
Average volume (90 days) 5.87M
Price summary
52-Week low 0.84
52-Week high 4.31
Beta -
50-Day moving average 1.46
200-Day moving average 2.43
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -297.48%
Operating margin -330.44%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.38%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.45
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.21
Current ratio (mrq) 10.14%
Book value per share (mrq) 1.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
